Rogers R D, Lancaster M, Wakeley J, Bhagwagar Z
University Department of Psychiatry, Warneford Hospital, Oxford, OX3 7JX, United Kingdom.
Psychopharmacology (Berl). 2004 Mar;172(2):157-64. doi: 10.1007/s00213-003-1641-5. Epub 2004 Jan 10.
Converging evidence from studies with neurological patients and brain imaging studies with healthy volunteers suggests that the capacity to make choices between actions associated with probabilistic rewards and punishments depends upon a network of cortico-limbic systems including the orbitofrontal cortex, cingulate cortex, amygdala and striatum. The involvement of such structures highlights the emotional aspects of decision-making and suggests that decision-making may be sensitive to manipulations of the catecholamine systems that innervate these structures. In this study, we investigated the possible role of noradrenaline (NA).
We examined the effects of a single oral 80 mg dose of the beta-adrenoceptor blocker, propranolol, on the decision-making of healthy volunteers in a double-blind, placebo-controlled, between-subjects design.
Seventeen volunteers ingested a placebo while 15 volunteers ingested propranolol. Visual analogue scales, and self-reported positive and negative ratings, were used to assess subjective changes and mood. Vital signs were also monitored. Seventy-five minutes after treatment, volunteers were asked to make a series of choices between two simultaneously presented gambles, differing in the magnitude of possible gains (i.e. reward), the magnitude of possible losses (i.e. punishment), and the probabilities with which these outcomes were delivered. Volunteers also chose between gambles probing identified non-cognitive biases in human decision-making, namely, risk-aversion when choosing between gains and risk-seeking when choosing between losses.
Propranolol treatment did not result in gross changes in subjective state or mood in comparison to placebo, but did slow heart rate significantly. Propranolol produced a selective change in volunteers' decision-making; namely, it significantly reduced the discrimination between large and small possible losses when the probability of winning was relatively low and the probability of losing was high.
These results suggest that NA modulates the processing of punishment signals when choosing between probabilistic rewards and punishments under conditions of increased arousal.
对神经疾病患者的研究以及对健康志愿者的脑成像研究得出的越来越多的证据表明,在与概率性奖励和惩罚相关的行动之间做出选择的能力取决于一个包括眶额皮质、扣带回皮质、杏仁核和纹状体在内的皮质-边缘系统网络。这些结构的参与突出了决策的情感方面,并表明决策可能对支配这些结构的儿茶酚胺系统的操纵敏感。在本研究中,我们调查了去甲肾上腺素(NA)的可能作用。
我们采用双盲、安慰剂对照、受试者间设计,研究了单次口服80毫克β-肾上腺素能受体阻滞剂普萘洛尔对健康志愿者决策的影响。
17名志愿者服用安慰剂,15名志愿者服用普萘洛尔。使用视觉模拟量表以及自我报告的正面和负面评分来评估主观变化和情绪。还监测了生命体征。治疗75分钟后,要求志愿者在两个同时呈现的赌博之间做出一系列选择,这两个赌博在可能收益的大小(即奖励)、可能损失的大小(即惩罚)以及这些结果出现的概率方面有所不同。志愿者还在探测人类决策中已确定的非认知偏差的赌博之间进行选择,即在收益之间选择时的风险规避和在损失之间选择时的风险寻求。
与安慰剂相比,普萘洛尔治疗并未导致主观状态或情绪的总体变化,但确实显著降低了心率。普萘洛尔使志愿者的决策产生了选择性变化;即,当获胜概率相对较低且失败概率较高时,它显著降低了对大小可能损失之间的区分。
这些结果表明,在唤醒增加的情况下,去甲肾上腺素在概率性奖励和惩罚之间进行选择时调节惩罚信号处理。